Tafenoquine Gets FDA Advisory Committee Nod for ApprovalBy mrvta - July 12, 2018Facebook Twitter Linkedin Email Print The FDA Antimicrobial Drugs Advisory Committee today voted to recommended approval of GSK’s tafenoquine for the radical cure of Plasmodium vivax infections in patients 16 years and older.
